Sugi Predict

Sugi Predict / Compounds / SCHEMBL23934786

SCHEMBL23934786

SCHEMBL23934786

C=C(CF)[C@@H]1CCC(C)=C[C@H]1c1c(OC(C)=O)cc(CCCCC)cc1OC(C)=O

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 4/20 0.85
▸ ACE2 Q9BYF1 4/20 0.64
▸ BCHE P06276 1/20 0.60
▸ CNR2 P34972 4/20 0.58
▸ CNR1 P21554 3/20 0.58
▸ TRPV1 Q8NER1 2/20 0.58
▸ MLNR O43193 1/20 0.58
▸ NR1I2 O75469 1/20 0.58
▸ PDE9A O76083 1/20 0.58
▸ ABCB11 O95342 1/20 0.58
▸ LDHA P00338 1/20 0.58
▸ CYP1A1 P04798 1/20 0.58
▸ CYP1A2 P05177 1/20 0.58
▸ CHRM2 P08172 1/20 0.58
▸ CYP3A4 P08684 1/20 0.58
▸ HTR1A P08908 1/20 0.58
▸ ADORA3 P0DMS8 1/20 0.58
▸ CYP2D6 P10635 1/20 0.58
▸ CYP2A6 P11509 1/20 0.58
▸ CYP2C9 P11712 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17299110 1.00 OPRM1 (0.85) OPRM1ACE2BCHECNR2CNR1
SCHEMBL17299109 0.92 OPRM1 (1.00) OPRM1ACE2BCHECNR2CNR1
SCHEMBL17299108 0.91 OPRM1 (0.86) OPRM1ACE2BCHECNR2CNR1
SCHEMBL7857365 0.91 OPRM1 (0.86) OPRM1ACE2BCHECNR2CNR1
SCHEMBL19472315 0.91 OPRM1 (0.86) OPRM1ACE2BCHECNR2CNR1
SCHEMBL26113351 0.90 OPRM1 (0.84) OPRM1ACE2BCHECNR2CNR1
SCHEMBL30741333 0.88 OPRM1 (0.81) OPRM1ACE2BCHECNR2CNR1
SCHEMBL31177567 0.88 OPRM1 (0.81) OPRM1ACE2BCHECNR2CNR1
SCHEMBL13940785 0.86 OPRM1 (0.79) OPRM1ACE2BCHECNR2CNR1
SCHEMBL29489984 0.86 OPRM1 (0.79) OPRM1ACE2BCHECNR2CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250339399-A1 SUPRAMOLECULAR SELF-ASSEMBLY SYSTEM BEIJING CREATRON INSTITUTE OF PHARMACEUTICAL RES CO LTD (CN) 2025-11-06 — — US claimed
CN-118660707-A Supermolecule self-assembly system 北京睿创康泰医药研究院有限公司 2024-09-17 — — CN claimed
US-20250339399-A1 SUPRAMOLECULAR SELF-ASSEMBLY SYSTEM BEIJING CREATRON INSTITUTE OF PHARMACEUTICAL RES CO LTD (CN) 2025-11-06 — — US disclosed
CN-118660707-A Supermolecule self-assembly system 北京睿创康泰医药研究院有限公司 2024-09-17 — — CN disclosed
WO-2023193244-A1 SUPRAMOLECULAR SELF-ASSEMBLY SYSTEM 北京睿创康泰医药研究院有限公司 2023-10-12 — — WO disclosed
WO-2023193244-A1 SUPRAMOLECULAR SELF-ASSEMBLY SYSTEM 北京睿创康泰医药研究院有限公司 2023-10-12 — — WO disclosed
US-20210322365-A1 POLYCANNABINOIDS, COMPOUNDS, COMPOSITIONS AND METHODS OF USE UNIVERSITY OF CONNECTICUT 2021-10-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250339399-A1 SUPRAMOLECULAR SELF-ASSEMBLY SYSTEM S100A8, TP53, AQP1 OPRM1 4804/4885ACE2 863/4885BCHE 975/4885
US-20210322365-A1 POLYCANNABINOIDS, COMPOUNDS, COMPOSITIONS AND METHODS OF USE CNR2, CNR1, GPR18 OPRM1 126/4885ACE2 3185/4885BCHE 1779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.